Related Experiment Videos
Risk assessment and risk stratification in sudden cardiac death: a biostatistician's view
1Division of Environmental and Occupational Health, School of Public Health, University of Minnesota, Minneapolis, USA. trc@cccs.umn.edu
Insights
Risk assessment and stratification help predict lethal arrhythmia development. Effective methods minimize bias and utilize multiple predictors, guiding personalized medical interventions.
Area of Science:
- Cardiology
- Biostatistics
- Medical Informatics
Background:
- Risk assessment and stratification are crucial for predicting lethal arrhythmia.
- Distinguishing these from screening, diagnosis, and staging is essential for appropriate application.
- Challenges include bias, multiple predictors, and result evaluation.
Purpose of the Study:
- To examine the key purpose of risk assessment and stratification.
- To analyze the role of operational definitions and methods accounting for multiple predictors and confounders.
- To illustrate potential pitfalls and the utility of multivariate techniques.
Main Methods:
- Analysis of operational definitions for predictors and events.
- Application of multivariate techniques to handle multiple predictors and confounding factors.
- Design and interpretation of a trial to evaluate risk stratification.
Main Results:
- Bias from regression to the mean can be minimized through averaging measurements or equalizing bias.
- Combined predictors can offer greater discrimination than individual variables.
- Randomized trials within risk strata demonstrate the utility of stratification for intervention responsiveness.
Conclusions:
- Multivariate techniques enhance discrimination of multiple predictors but increase complexity.
- Careful methodology and evaluation studies are vital to avoid pitfalls in risk stratification.
- Randomized trials of treatment provide definitive evidence for the clinical utility of risk stratification.
Abstract:
Determining individual probabilities of developing lethal arrhythmia over time (risk assessment) and grouping individuals by that probability (risk stratification) are similar to, yet differ in purpose from, screening, diagnosis, risk factor identification, and prognostic staging. Methods of handling bias, use of multiple predictors, and evaluation of results provide challenges. A key purpose of risk assessment and stratification is examined. The role of operational definitions of predictors and events and of methods that account for multiple predictors and known confounding factors is analyzed. Constructed examples illustrate potential pitfalls in assessment and how multivariate techniques can deal with multiple predictors. A trial design to evaluate risk stratification for the identified purpose is elaborated and potential results are interpreted. Bias from predictors regressing to the mean can be minimized either by averaging a number of measurements or by equalizing the bias in comparison groups. An analysis of two predictors and two risk strata illustrates how the discrimination of combined predictors may be greater than the sum of the individual variables' discrimination. Risk stratification can be evaluated in trials that randomize competing interventions within different risk strata. Results of such trials indicate whether the risk strata adequately distinguish individuals by their responsiveness to particular intervention. Potential pitfalls, not easily recognized in risk stratification, can be avoided in the methods and in studies for evaluating those methods. Multivariate techniques maximize the discrimination of multiple predictors, but may increase complexity. Randomized trials of treatment provide evidence for utility of risk stratification.